If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

New research shows patients with Parkinson's disease were more willing to help others after taking their dopamine-boosting ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

A research team from the University of Cologne conducted one of the most comprehensive studies on dopamine and ...

Discover the impact of dopamine on the brain's reward circuit, from pleasure to addiction, and how to find balance.

In one of the largest studies of its kind, researchers found that increasing dopamine levels with L-DOPA made people slightly ...

Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.

LOS ANGELES — Maybe you'd like to spend time on hobbies or hang out with friends, but nothing feels as exciting and engaging as it used to –– so you just squander another hour on social media. Your ...

Researchers at School of Medicine and Tufts Graduate School of Biomedical Sciences have found a surprising connection ...